Partial characterization of a cysteine protease inhibitor of Plasmodium vivax. [PDF]
Võ TC, Kang JM, Lê HG, Na BK.
europepmc +1 more source
Oncometabolite fumarate impairs ATR-CHK1 signaling by succinating RPA1 in fumarate hydratase-deficient renal cell carcinoma cells. [PDF]
Liu N +12 more
europepmc +1 more source
Machine learning-driven docking of diverse DDAs as promising cysteine protease inhibitors targeting Mpox virus. [PDF]
Alotaibi BS +6 more
europepmc +1 more source
Correction: Dynamic expression of cathepsin L in the black soldier fly (Hermetia illucens) gut during Escherichia coli challenge. [PDF]
Chiang YR +4 more
europepmc +1 more source
Cathepsins as Core Players in Obesity Pathogenesis: Emerging Therapeutic Targets. [PDF]
Xie J, Mei Y, Guan H, Xia X, Ding W.
europepmc +1 more source
Basic research on the PEDV infection cycle and virus–host interactions advances the development of anti‐PEDV drugs and disease‐resistant breeding and helps strengthen disease prevention and control while reducing economic losses in the swine industry.
Heyong Wu +8 more
wiley +1 more source
The Differential Redox Resilience of Alvelestat and Sivelestat: A Mechanistic Hypothesis for Inhibitor Performance Under Oxidative Stress. [PDF]
D'Amato M +9 more
europepmc +1 more source
ABSTRACT The agitation power input substantially impacts the oxygen transfer rate in aerobic fermentation processes. Furthermore, in a carbon‐limited process where the substrate feed rate is controlled by the concentration of dissolved oxygen, the power input will consequently govern the feed rate.
Mariana Albino +6 more
wiley +1 more source
Sulfur-Containing Amino Acids: The Conversion Process from Product to Substrate. [PDF]
Zheng P, Jin Y, Wei C, Xia C.
europepmc +1 more source
Microbial Hydrolysates as Amino Acid Source in Cell Culture Media for Cellular Agriculture
ABSTRACT The high cost of cultivation media remains one of the barriers to the commercialization of cultivated meat. Current serum‐free media reduce reliance on fetal bovine serum but only achieve modest cost savings. Especially at larger scales (> 20 m3), pharmaceutical‐grade amino acids and recombinant proteins remain major cost drivers.
Jelle C. Hoek +3 more
wiley +1 more source

